Norges Bank Recursion Pharmaceuticals, Inc. Transaction History

Norges Bank

$716 Trillion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$7.35 - $10.05 $14.3 Million - $19.6 Million	1,947,295 New	1,947,295 $14.6 Million
Q4 2023 Feb 09, 2024	BUY	$5.09 - $10.79 $18 Million - $38.1 Million	3,531,964 New	3,531,964 $34.8 Million
Q3 2023 Nov 13, 2024	BUY	$6.59 - $15.86 $22.6 Million - $54.3 Million	3,426,256 New	3,426,256 $26.2 Million
Q3 2023 Nov 13, 2023	SELL	$6.59 - $15.86 $28.8 Million - $69.3 Million	-4,371,313 Closed	0 $0
Q2 2023 Aug 14, 2024	BUY	$4.56 - $9.94 $4.19 Million - $9.14 Million	919,923 Added 47.24%	2,867,218 $21.4 Million
Q2 2023 Aug 14, 2023	SELL	$4.56 - $9.94 $19.4 Million - $42.3 Million	-4,255,307 Closed	0 $0
Q1 2023 May 15, 2024	BUY	$6.42 - $9.64 $27.1 Million - $40.7 Million	4,226,086 New	4,226,086 $28.2 Million
Q4 2022 Feb 14, 2023	BUY	$7.16 - $12.7 $31.3 Million - $55.5 Million	4,371,313 New	4,371,313 $33.7 Million
Q3 2022 Nov 13, 2023	BUY	$7.83 - $13.6 $34.2 Million - $59.4 Million	4,371,313 New	4,371,313 $46.5 Million
Q2 2022 Aug 14, 2023	BUY	$5.04 - $9.26 $21.4 Million - $39.4 Million	4,255,307 New	4,255,307 $34.6 Million
Q1 2022 May 12, 2023	SELL	$6.16 - $18.03 $18.3 Million - $53.6 Million	-2,974,038 Reduced 68.04%	1,397,275 $10 Million
Q1 2022 May 09, 2022	SELL	$6.16 - $18.03 $8.61 Million - $25.2 Million	-1,397,274 Closed	0 $0
Q4 2021 Mar 09, 2022	BUY	$16.14 - $21.86 $22.6 Million - $30.5 Million	1,397,274 New	1,397,274 $23.9 Million
Q3 2021 Nov 14, 2022	BUY	$19.03 - $41.33 $9.52 Million - $20.7 Million	500,000 New	500,000 $11.5 Million
Q3 2021 Nov 05, 2021	SELL	$19.03 - $41.33 $9.52 Million - $20.7 Million	-500,000 Closed	0 $0
Q2 2021 Aug 15, 2022	BUY	$18.0 - $37.42 $9 Million - $18.7 Million	500,000 New	500,000 $18.3 Million

Others Institutions Holding RXRX

# of Institutions

286

Shares Held

242M

Call Options Held

1.35M

Put Options Held

2.32M

Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

32.8M
Shares

$203 Million
2.05% of portfolio
Baillie Gifford & CO

25.2M
Shares

$156 Million
0.13% of portfolio
Vanguard Group Inc Valley Forge, PA

24.3M
Shares

$150 Million
0.0% of portfolio
Black Rock Inc. New York, NY

17.3M
Shares

$107 Million
0.0% of portfolio
Ra Capital Management, L.P. Boston, MA

15.4M
Shares

$95.1 Million
1.41% of portfolio

View Full List

About RECURSION PHARMACEUTICALS, INC.

Ticker RXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 180,480,000
Market Cap $1.12B
Description
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...

More about RXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Account